Tumoral Calcium Pyrophosphate Dihydrate Crystal Deposition Disease

• Published in: Pathology, research and practice Vol. 197; no. 7; pp. 499 - 506
• Main Authors: Yamakawa, Koji, Iwasaki, Hiroshi, Ohjimi, Yuko, Kikuchi, Masahiro, Iwashita, Akinori, Isayama, Teruto, Naito, Masatoshi
• Format: Journal Article
• Language: English
• Published: Elsevier GmbH 2001
• Subjects: Calcinosis; Chondrosarcoma; Gout; Tumoral calcium pyrophosphate dihydrate crystal deposition disease (CPPDCD); Chondrosarcoma; Tumoral calcium pyrophosphate dihydrate crystal deposition disease (CPPDCD); Calcinosis; Gout
• ISSN: 0344-0338; 1618-0631
• DOI: 10.1078/0344-0338-00118

We describe five cases of tumoral calcium pyrophosphate dihydrate crystal deposition disease (CPPDCD) and discuss the clinical, radiological and pathological features. Patients included 4 males and 1 female, ranging in age from 49 to 70 years (median, 63 yrs). The wrist was involved in two patients. The thumb, palmar aspect of the proximal phalanx of the middle finger and dorsum of the carpal bone of the hand were involved in one patient each. In one patient, a preoperative diagnosis of chondrosarcoma had been made. Macroscopically, the lesion was a circumscribed whitish-gray mass with a more or less chalky appearance, measuring between 1.0 to 6.2 cm (median, 2.5 cm).Histologically, all five lesions contained areas of calcification with crystal deposits and chondroid metaplasia. The majority of crystals were rhomboid in shape, characteristic of CPPD, but some needle-shaped crystals were also identified, which resembled urate crystals. A review of the 54 reported cases of tumoral CPPDCDincluding our series indicated that they could be divided into two categories based on anatomic location: central (head and neck) type (n = 33) and distal (extremity) type (n = 21). Patients of these two groups were not different with respect to age and gender, but those with the central type often presented with a painful mass (15 patients, 46%), or neurological disturbances (11 patients, 33%). Patients with the distal type presented with a painless mass or swelling (12 patients, 57%), but none had neurological signs, although 8 (38.1%) presented with acute attack similar to tophaceous gout. Tumoral CPPDCD should be differentiated from tophaceous gout, tumoral calcinosis, and malignant or benign tumors.